Literature DB >> 23807731

Measurement of accelerometry-based gait parameters in people with and without dementia in the field: a technical feasibility study.

M Gietzelt1, K-H Wolf, M Kohlmann, M Marschollek, R Haux.   

Abstract

BACKGROUND: Gait analyses are an important tool to diagnose diseases or to measure the rehabilitation process of patients. In this context, sensor-based systems, and especially accelerometers, gain in importance. They are able to improve objectiveness of gait analyses. In clinical settings, there is usually a supervisor who gives instructions to the patients, but this can have an influence on patients' gait. It is expected that this effect will be smaller in field studies.
OBJECTIVE: Aim of this study was to capture and evaluate gait parameters measured by a single waist-mounted accelerometer during everyday life of subjects.
METHODS: Due to missing ground-truth in unsupervised conditions, another external criterion had to be chosen. Subjects of two different groups were considered: patients with dementia (DEM) and active older people (ACT). These groups were chosen, because of the expected difference in gait. The idea was to quantify the expected difference of accelerometric-based gait parameters. Gait parameters were e.g. velocity, step frequency, compensation movements, and variance of the accelerometric signal.
RESULTS: Ten subjects were measured in each group. The number of walking episodes captured was 1,187 (DEM) vs. 1,809 (ACT). The compensation and variance parameters showed an AUC value (Area Under the Curve) between 0.88 and 0.92. In contrast, velocity and step frequency performed poorly (AUC values of 0.51 and 0.55). It was possible to classify both groups using these parameters with an accuracy of 89.2%.
CONCLUSION: The results showed a much higher amount of walking episodes in field studies compared to supervised clinical trials. The classification showed a high accuracy in distinguishing between both groups.

Entities:  

Mesh:

Year:  2013        PMID: 23807731     DOI: 10.3414/ME12-02-0009

Source DB:  PubMed          Journal:  Methods Inf Med        ISSN: 0026-1270            Impact factor:   2.176


  7 in total

1.  A collaboration tool based on SNOCAP-HET.

Authors:  Martin Kohlmann; Matthias Gietzelt; Nico Jähne-Raden; Michael Marschollek; Bianying Song; Klaus-Hendrik Wolf; Reinhold Haux
Journal:  J Med Syst       Date:  2013-11-16       Impact factor: 4.460

2.  [Gerontechnology between acceptance and evidence: results of the Lower Saxony Research Network "Design of Environments for the Ageing"].

Authors:  M Marschollek; H Künemund
Journal:  Z Gerontol Geriatr       Date:  2014-12       Impact factor: 1.281

Review 3.  Remote Physical Activity Monitoring in Neurological Disease: A Systematic Review.

Authors:  Valerie A J Block; Erica Pitsch; Peggy Tahir; Bruce A C Cree; Diane D Allen; Jeffrey M Gelfand
Journal:  PLoS One       Date:  2016-04-28       Impact factor: 3.240

4.  Classification of Alzheimer's Patients through Ubiquitous Computing.

Authors:  Alicia Nieto-Reyes; Rafael Duque; José Luis Montaña; Carmen Lage
Journal:  Sensors (Basel)       Date:  2017-07-21       Impact factor: 3.576

Review 5.  The Role of Movement Analysis in Diagnosing and Monitoring Neurodegenerative Conditions: Insights from Gait and Postural Control.

Authors:  Christopher Buckley; Lisa Alcock; Ríona McArdle; Rana Zia Ur Rehman; Silvia Del Din; Claudia Mazzà; Alison J Yarnall; Lynn Rochester
Journal:  Brain Sci       Date:  2019-02-06

6.  Clinical evaluation of a mobile sensor-based gait analysis method for outcome measurement after knee arthroplasty.

Authors:  Tilman Calliess; Raphael Bocklage; Roman Karkosch; Michael Marschollek; Henning Windhagen; Mareike Schulze
Journal:  Sensors (Basel)       Date:  2014-08-28       Impact factor: 3.576

7.  Use of nonintrusive sensor-based information and communication technology for real-world evidence for clinical trials in dementia.

Authors:  Stefan Teipel; Alexandra König; Jesse Hoey; Jeff Kaye; Frank Krüger; Julie M Robillard; Thomas Kirste; Claudio Babiloni
Journal:  Alzheimers Dement       Date:  2018-06-21       Impact factor: 21.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.